News for Ekso Bionics Holdings, Inc. (0IFR.L)

Ekso Bionics (EKSO) recently experienced a halting of its stock trading activities, with an important announcement anticipated shortly. This pause in trading su

Ekso Bionics (EKSO) has rescheduled its 1-for-15 reverse stock split to June 2, 2025. The reverse split will reduce outstanding shares from approximatel

**media[633513]**

U.S. stocks traded lower midway through trading, with the Dow Jones index falling more than 150 points on Tuesday. The Dow traded down 0.37% to 42,632.71 while...

U.S. stocks traded lower this morning, with the Nasdaq Composite falling more than 100 points on Tuesday. Following the market opening Tuesday, the Dow traded ...

U.S. stock futures were slightly lower on Tuesday after ending largely flat on Monday. Futures of major benchmark indices were trading lower in premarket.

With U.S. stock futures trading lower this morning on Tuesday, some of the stocks that may grab investor focus today are as follows: Wall Street expects The Ho...

SAN RAFAEL, Calif., May 19, 2025 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (the ”œCompany”) ( EKSO), a leading developer of exoskeletons for medical

Ekso Bionics (EKSO) Holdings has joined the prestigious NVIDIA Connect program, a move aimed at leveraging cutting-edge tools and resources. Through this collab

Ekso Bionics Holdings (EKSO) recently experienced a notable change in its target price, as reported by HC Wainwright & Co. The firm's analyst, Swayampakula Rama

H.C. Wainwright has revised its price target for Ekso Bionics (EKSO), cutting it to $4 from the previous $9. Despite this adjustment, the firm maintains a Buy r

Release Date: May 05, 2025For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Ekso Bionics Hold

Refinitiv StreetEvents Event TranscriptE D I T E D V E R S I O NEKSO.OQ - Ekso Bionics Holdings IncQ1 2025 Ekso Bionics Holdings Inc Earnings CallMay 05, 2025

Summary: Ekso Bionics (EKSO) Q1 2025 revenue decreased to $3.4 million, but gross margins improved significantly to 54% due to better cost management. An

SAN RAFAEL, Calif., May 05, 2025 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. ( EKSO) (”œEkso Bionics” or the ”œCompany”), an industry leader in exos

SAN RAFAEL, Calif., April 28, 2025 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. ( EKSO) (the ”œCompany”), an industry leader in exoskeleton technology f

**media[608100]**

Ekso Bionics looks to sell 10.5 million shares of its common stock, suggesting strategic moves by existing stakeholders. Analyst price targets for EKSO

Shares of Chanson International Holding CHSN rose sharply in today's pre-market trading after reported a year-over-year increase in FY24 financial results. Cha...